HighTower Advisors’s Repligen RGEN Stock Holding History

HighTower Advisors’s Portfolio RGEN Stock Details RGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-800	Closed	-$26.4K	–	3910
2025 Q3	$26.4K	Buy	+800	New	+$97.2K	﹤0.01%	3651

Other funds holding RGEN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

UCFA

United Capital Financial Advisors Irving, Texas $18.2B AUM 22.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

HighTower Advisors's RGEN Position: Q2 2026 in Review

HighTower Advisors sold out of Repligen (RGEN) in Q2 2026, closing a stake of 1,759 shares — an estimated $207K sold.

HighTower Advisors first reported a position in RGEN in Q3 2017 and held it in 35 quarters. The position peaked at $5.15M in Q3 2021. 481 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.

HighTower Advisors reported no remaining Repligen position as of Q2 2026 after selling out during the quarter.
HighTower Advisors sold 1,759 Repligen shares in Q2 2026, an estimated $207K.
HighTower Advisors first reported a position in Repligen in Q3 2017 and held it in 35 quarters.
HighTower Advisors's Repligen position peaked at $5.15M in Q3 2021.
481 funds tracked by Wall St. Rank held Repligen as of Q2 2026.

Based on HighTower Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.